21 views
3 weeks ago General
US drugmakers Merck and Moderna said Wednesday a personalised cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a "breakthrough." Researchers have for years been trying to apply mRNA treatments against cancer, but this was the first time such a drug showed positive results in a large, late-stage clinical trial.
#cancer #melanoma #health
🔔 Subscribe to France 24 now: https://f24.my/YTen
🔴 LIVE - Watch FRANCE 24 English 24/7 here: https://f24.my/YTliveEN
🌍 Read the latest International News and Top Stories: https://www.france24.com/en/
Like us on Facebook: https://f24.my/FBen
Follow us on X: https://f24.my/Xen
Bluesky: https://f24.my/BSen and Threads: https://f24.my/THen
Browse the news in pictures on Instagram: https://f24.my/IGen
Discover our TikTok videos: https://f24.my/TKen
Get the latest top stories on Telegram: https://f24.my/TGen